Cyclacel Pharmaceuticals Inc. (CYCC) Declined -5.61% or -0.06 To Price $1.01 On Tuesday


Cyclacel Pharmaceuticals Inc. (CYCC) declined -5.61% or -0.06 to $1.01. It is approximately 26457 shares traded, which is 17.52% compare to the average total volume 150996. The market cap of CYCC is $12.62 million. The year to date change is -44.81%. The 52 week price range is from $1.0 to $2.25. Price of CYCC have changed -10.83% during last week. It have changed -23.02% over last month, -26.21% over last 3 months, -23.02% over last 6 months and -38.51% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CYCC is 1.33. It is 31.68% above current price. The 200-day Moving Averages for CYCC is 1.46. It is 44.55% above current price. The 52-week High is 2.25. It is 122.77% from the current price. The 52-week Low is 1.0. It is -0.99% from current price.

There are some statistics of CYCC. It is has market cap $12.62 million. The share outstanding is 12.50 million. The average volume is 150996. The percent of top 15 Institution holding is 8.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CYCC is -37.48%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CYCC is -30.92%.


Tags:

Share this post